GE Equity International Mauritius, a subsidiary of GE Capital has invested Rs. 125 crore ($23 million) to acquire 7.69 per cent equity stake in Syngene International, Biocon’s research services subsidiary..AZB & Partners advised GE Equity International Mauritius with a team led by Partner Essaji Vahanvati along with Senior Associate Nandish Vyas..Mundkur Law Partners advised Biocon with a team led by Managing Partner Ramanand Mundkur..According to Dealcurry, Biocon will utilize the funds to expand its integrated discovery and development services platform and tap the global outsourcing opportunity through partnerships with leading pharma and biotech companies..Late last year Biocon had announced the listing of its custom research unit, Syngene in the next 18 months and the recent funding takes it closer to the intended purpose.
GE Equity International Mauritius, a subsidiary of GE Capital has invested Rs. 125 crore ($23 million) to acquire 7.69 per cent equity stake in Syngene International, Biocon’s research services subsidiary..AZB & Partners advised GE Equity International Mauritius with a team led by Partner Essaji Vahanvati along with Senior Associate Nandish Vyas..Mundkur Law Partners advised Biocon with a team led by Managing Partner Ramanand Mundkur..According to Dealcurry, Biocon will utilize the funds to expand its integrated discovery and development services platform and tap the global outsourcing opportunity through partnerships with leading pharma and biotech companies..Late last year Biocon had announced the listing of its custom research unit, Syngene in the next 18 months and the recent funding takes it closer to the intended purpose.